The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $132.61

Today's change-0.27 -0.20%
Updated February 9 10:30 AM EST. Delayed by at least 15 minutes.
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $132.61

Today's change-0.27 -0.20%
Updated February 9 10:30 AM EST. Delayed by at least 15 minutes.

Becton Dickinson and Co down (U.S.)$0.27

Becton Dickinson and Co is lower today, dropping (U.S.)$0.27 or 0.20% to (U.S.)$132.61. Over the last five days, shares have lost 8.58% and sit 2.90% above their 52-week low. This security has outperformed the S&P 500 by 3.67% during the last year.

Key company metrics

  • Open(U.S.) $129.58
  • Previous close(U.S.) $132.88
  • High(U.S.) $133.13
  • Low(U.S.) $129.50
  • Bid / Ask(U.S.) $132.38 / (U.S.) $132.58
  • YTD % change-13.94%
  • Volume389,652
  • Average volume (10-day)1,518,045
  • Average volume (1-month)1,347,536
  • Average volume (3-month)1,094,622
  • 52-week range(U.S.) $128.87 to (U.S.) $157.50
  • Beta1.03
  • Trailing P/E39.01×
  • P/E 1 year forward15.80×
  • Forward PEG1.19×
  • Indicated annual dividend(U.S.) $2.64
  • Dividend yield1.99%
  • Trailing EPS(U.S.) $3.40
Updated February 9 10:30 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.75%

Based on its net profit margin of 6.75%, Becton Dickinson and Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.29%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue3,0603,1202,0512,051
Total other revenue--------
Total revenue3,0603,1202,0512,051
Gross profit1,4161,1881,0461,045
Total cost of revenue1,6441,9321,0051,006
Total operating expense2,7652,9831,7581,702
Selling / general / administrative743764511544
Research & development195178129129
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)18210811323
Other operating expenses, total11----
Operating income295137293349
Interest income (expense), net non-operating-99-105-91-76
Gain (loss) on sale of assets--------
Other--------
Income before tax19039225285
Income after tax18162216235
Income tax, total9-23950
Net income18162216235
Total adjustments to net income------1
Net income before extra. items18162216235
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18162216236
Inc. avail. to common incl. extra. items18162216236
Diluted net income18162216236
Dilution adjustment------0
Diluted weighted average shares217215200197
Diluted EPS excluding extraordinary itemsvalue per share0.830.291.081.20
Dividends per sharevalue per share0.600.600.600.60
Diluted normalized EPSvalue per share1.630.621.621.29